MedDay Secures €34 Million ($38.5M) New Funding
Posted: Fri Apr 08, 2016 8:58 am
Please visit this web:
http://www.medday-pharma.com/
http://www.medday-pharma.com/
Welcome to This is MS, the leading forum for Multiple Sclerosis research and support. Join our friendly community of patients, caregivers, and researchers celebrating over 20 years of delivering hope through knowledge.
https://www.thisisms.com/forum/
Does anyone know if the following statement only relates to people who were in the original studies? or is there a method to access the MD100 (as opposed to sourcing your own Biotin)?Friday, April 08, 2016
MedDay Secures €34 Million ($38.5M) New Funding
Edmond de Rothschild Investment Partners led the Series B financing alongside existing investors Sofinnova Partners and InnoBio. Large Venture also participated in the operation.
Funds will drive a confirmatory phase 3 study in US to treat progressive multiple sclerosis with MedDay’s wholly-owned lead candidate, MD1003
The drug is already commercialized in some European countries under “named patient use”.